Abbott Enters Agreement With Cincinnati Children
Abbott has signed an exclusive agreement with Cincinnati Children’s Hospital to develop a urine-based diagnostic assay to detect kidney injury and disease using the protein neutrophil gelatinase-associated lipocalin (NGAL).
Read More